Screening and Verification COPD-OSA Overlap Syndrome Core Genes Using Bioinformatics.

IF 3.1 3区 医学 Q2 RESPIRATORY SYSTEM
Shihao Qiang, Rongrong Wan, Jingyi Wu, Chao Wang, Xiaochuan Cui, Yunyun Zhang
{"title":"Screening and Verification COPD-OSA Overlap Syndrome Core Genes Using Bioinformatics.","authors":"Shihao Qiang, Rongrong Wan, Jingyi Wu, Chao Wang, Xiaochuan Cui, Yunyun Zhang","doi":"10.2147/COPD.S528703","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>When obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) coexist in a patient, it is called overlap syndrome (OS). However, the molecular mechanisms underpinning OS are unclear. To address this, we explored potential OS mechanisms using bioinformatics.</p><p><strong>Methods: </strong>OSA and COPD gene expression datasets were obtained from the Gene Expression Omnibus (GEO) database. Differential expression and weighted gene co-expression network analyses (WGCNA) were performed to identify common differentially expressed genes (DEGs) in OSA and COPD, and perform functional enrichment analysis. DEGs were validated in an external COPD gene expression dataset using receiver operating characteristic (ROC) curves and box plots. Positive results were initially identified as core genes, and were then validated by analyzing core genes in healthy controls, patients with OSA alone and patients with OS using RT-qPCR.</p><p><strong>Results: </strong>Through differential expression gene analysis, 9 common DEGs for OSA and COPD were identified. Through WGCNA analysis, 128 common key module genes for OSA and COPD were identified. By taking the intersection of the identified 9 DEGs and the 128 common key module genes from WGCNA, 5 key genes were determined. Preliminary validation in the external gene expression dataset for COPD revealed that <i>GRM8</i> was a potential hub gene for OS. Compared with the control group, the expression of <i>GRM8</i> was significantly downregulated in the COPD group (<i>P</i> = 0.019). The diagnostic value was evaluated using the ROC curve, and the results showed that the AUC was 0.857 (95% CI: 0.614-1.000). Finally, RT-qPCR confirmed that the expression levels of <i>GRM8</i> in OSA and OS were significantly lower than those in the healthy control group (<i>P</i> < 0.05), and it was a hub gene significantly associated with OS.</p><p><strong>Conclusion: </strong>Our research identified hub gene that may provide new directions for further mechanistic research on OS.</p>","PeriodicalId":48818,"journal":{"name":"International Journal of Chronic Obstructive Pulmonary Disease","volume":"20 ","pages":"2601-2614"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311238/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/COPD.S528703","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: When obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) coexist in a patient, it is called overlap syndrome (OS). However, the molecular mechanisms underpinning OS are unclear. To address this, we explored potential OS mechanisms using bioinformatics.

Methods: OSA and COPD gene expression datasets were obtained from the Gene Expression Omnibus (GEO) database. Differential expression and weighted gene co-expression network analyses (WGCNA) were performed to identify common differentially expressed genes (DEGs) in OSA and COPD, and perform functional enrichment analysis. DEGs were validated in an external COPD gene expression dataset using receiver operating characteristic (ROC) curves and box plots. Positive results were initially identified as core genes, and were then validated by analyzing core genes in healthy controls, patients with OSA alone and patients with OS using RT-qPCR.

Results: Through differential expression gene analysis, 9 common DEGs for OSA and COPD were identified. Through WGCNA analysis, 128 common key module genes for OSA and COPD were identified. By taking the intersection of the identified 9 DEGs and the 128 common key module genes from WGCNA, 5 key genes were determined. Preliminary validation in the external gene expression dataset for COPD revealed that GRM8 was a potential hub gene for OS. Compared with the control group, the expression of GRM8 was significantly downregulated in the COPD group (P = 0.019). The diagnostic value was evaluated using the ROC curve, and the results showed that the AUC was 0.857 (95% CI: 0.614-1.000). Finally, RT-qPCR confirmed that the expression levels of GRM8 in OSA and OS were significantly lower than those in the healthy control group (P < 0.05), and it was a hub gene significantly associated with OS.

Conclusion: Our research identified hub gene that may provide new directions for further mechanistic research on OS.

Abstract Image

Abstract Image

Abstract Image

利用生物信息学筛选和验证COPD-OSA重叠综合征核心基因。
背景:当阻塞性睡眠呼吸暂停(OSA)和慢性阻塞性肺疾病(COPD)共存时,称为重叠综合征(OS)。然而,支持OS的分子机制尚不清楚。为了解决这个问题,我们利用生物信息学探索了潜在的OS机制。方法:从gene expression Omnibus (GEO)数据库中获取OSA和COPD基因表达数据集。采用差异表达和加权基因共表达网络分析(WGCNA)鉴定OSA和COPD的共同差异表达基因(DEGs),并进行功能富集分析。deg在外部COPD基因表达数据集中使用受试者工作特征(ROC)曲线和箱形图进行验证。阳性结果最初被确定为核心基因,然后通过RT-qPCR分析健康对照、OSA单独患者和OS患者的核心基因进行验证。结果:通过差异表达基因分析,鉴定出OSA和COPD常见的9个deg。通过WGCNA分析,共鉴定出128个OSA和COPD的共同关键模块基因。将鉴定到的9个deg与WGCNA中128个常见关键模块基因相交,确定5个关键基因。在COPD外部基因表达数据集中的初步验证显示,GRM8是OS的潜在中枢基因。与对照组相比,COPD组GRM8表达明显下调(P = 0.019)。采用ROC曲线评价诊断价值,结果显示AUC为0.857 (95% CI: 0.614 ~ 1.000)。最后,RT-qPCR证实GRM8在OSA和OS中的表达水平均显著低于健康对照组(P < 0.05),是与OS显著相关的枢纽基因。结论:本研究确定了中枢基因,为进一步研究OS的机制提供了新的方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.80
自引率
10.70%
发文量
372
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信